Baba E, Erskine R, Boyson J E, Cohen G B, Davis D M, Malik P, Mandelboim O, Reyburn H T, Strominger J L
Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA.
Hum Immunol. 2000 Dec;61(12):1202-18. doi: 10.1016/s0198-8859(00)00184-1.
The possible role of carbohydrate in the interaction of HLA-C with a human inhibitory natural Killer cell Immunoglobulin-like Receptor with two Ig domains, KIR2DL1, was investigated. Transfectants of 721.221 (a class I MHC-negative human B cell line) expressing only HLA-Cw4 or -Cw6 or their respective non-glycosylated mutants (N86Q, S88A) were made. The binding of a KIR2DL1-Ig fusion protein to the non-glycosylated mutant HLA-Cw4- or -Cw6-expressing cells was markedly decreased compared to the wild type-expressing cells. The ability to induce an inhibitory signal in the NK tumor line YTS transfected with KIR2DL1 was also impaired in the nonglycosylated mutant expressing cells. Furthermore, in a second functional assay, mutant HLA-Cw4 and -Cw6 molecules had impaired ability to induce signal transduction in BW cells expressing a KIR2DL1-CD3 zeta chain chimeric protein. Thus, the deletion of the N-linked glycosylation signal in HLA-Cw4 and -Cw6 greatly reduced recognition by KIR2DL1. Alternative interpretations of the data are discussed.
研究了碳水化合物在HLA - C与具有两个Ig结构域的人类抑制性自然杀伤细胞免疫球蛋白样受体KIR2DL1相互作用中的可能作用。构建了仅表达HLA - Cw4或 - Cw6或其各自非糖基化突变体(N86Q、S88A)的721.221(一种I类MHC阴性人B细胞系)转染子。与表达野生型的细胞相比,KIR2DL1 - Ig融合蛋白与表达非糖基化突变体HLA - Cw4或 - Cw6的细胞的结合明显减少。在转染了KIR2DL1的NK肿瘤细胞系YTS中诱导抑制信号的能力在表达非糖基化突变体的细胞中也受损。此外,在第二项功能试验中,突变型HLA - Cw4和 - Cw6分子在表达KIR2DL1 - CD3ζ链嵌合蛋白的BW细胞中诱导信号转导的能力受损。因此,HLA - Cw4和 - Cw6中N - 连接糖基化信号的缺失大大降低了KIR2DL1的识别。文中讨论了对数据的其他解释。